VMD (Viemed Healthcare) EBIT: $22.8 Mil (TTM As of Mar. 2026)


VMD Viemed Healthcare Inc VMD
93 GF Score
Price $12.14
GF Value $10.90
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Viemed Healthcare EBIT?

Viemed Healthcare VMD +0.54% 93 EBIT is $22.8 Mil as of Mar. 2026. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.90 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Viemed Healthcare's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $4.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $22.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Viemed Healthcare's annualized ROC % for the quarter that ended in Mar. 2026 was 7.65%. Viemed Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 21.07%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Viemed Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.84%.


Viemed Healthcare  (NAS:VMD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Viemed Healthcare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=18.608 * ( 1 - 32.02% )/( (166.77 + 163.925)/ 2 )
=12.6497184/165.3475
=7.65 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Viemed Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=17.184/( ( (82.355 + max(-3.998, 0)) + (79.308 + max(1.415, 0)) )/ 2 )
=17.184/( ( 82.355 + 80.723 )/ 2 )
=17.184/81.539
=21.07 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(25.586 + 5.047 + 4.132) - (24.947 + 7.52 + 6.296)
=-3.998

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(31.179 + 5.183 + 3.687) - (24.331 + 7.479 + 6.824)
=1.415

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Viemed Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=22.768/470.018
=4.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viemed Healthcare EBIT Related Terms


Viemed Healthcare EBIT Historical Data

* Premium members only.

The historical data trend for Viemed Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viemed Healthcare EBIT Chart

Viemed Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.82 9.19 14.82 16.95 22.95

Viemed Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.84 4.46 5.64 8.37 4.30

VMD vs DCTH, VREX, SI: EBIT Comparison

For the Medical Devices subindustry, Viemed Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viemed Healthcare EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Viemed Healthcare's EV-to-EBIT falls into.


VMD
93GF Score
Viemed Healthcare Inc VMD
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viemed Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $22.8 Mil mean?
Viemed Healthcare (VMD) has a EBIT of $22.8 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Viemed Healthcare.
Is Viemed Healthcare's EBIT too high?
Viemed Healthcare's current EBIT is $22.8 Mil. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's EBIT compare to DCTH and VREX?
Viemed Healthcare's EBIT of $22.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Viemed Healthcare. Viemed Healthcare's current EBIT is $22.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.90, compared to a current price of $12.14 — trading 11.4% above its estimated fair value. The current EBIT is $22.8 Mil. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current EBIT is $22.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viemed Healthcare (VMD) Overvalued in 2026?

Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued. The current stock price of $12.14 is trading 11.4% above its estimated GF Value™ of $10.90. GuruFocus considers Viemed Healthcare to be Modestly Overvalued.

Key valuation signals for VMD:

  • EBIT: $22.8 Mil
  • GF Value™: $10.90 vs. price of $12.14 (11.4% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viemed Healthcare Business Description

Other Exchanges VIJ:Germany
Address 625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score

Get the complete analysis for VMD

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.14
Price
$10.90
GF Value